Large-scale testing (Phase 3)Looking for participantsNCT07648264
What this trial is testing
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Who this might be right for
Secondary Immune Deficiency
CSL Behring 63